This invention is ON FORMULATIONS FOR SPRAY USE medication administration by inhalation, particularly a pharmaceutical formulation aerosol comprising: (A) MONOHYDRATE beclomethasone dipropionate, with the particle size of substantially all the monohydrate UNDER 20 microns; (B) at least 0.015% OF WATER FORMULATION additional water of crystallization associated weight said monohydrate; And (C) a propellant fluorocarbon or hydrogen-containing chlorofluorocarbon. Also it disclosed a method of treating BREATHING DISORDER which comprises administration by inhalation of an effective amount of a formulation PHARMACEUTICAL AEROSOL FOR AS DEFINED IN MEMORY.
展开▼